MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line-Reference-Cited by-同舟云学术

MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line

Published:2015-06-18 Issue:6 Volume:10 Page:e0130287
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Faggi Fiorella,Codenotti Silvia,Poliani Pietro Luigi,Cominelli Manuela,Chiarelli Nicola,Colombi Marina,Vezzoli Marika,Monti Eugenio,Bono Federica,Tulipano Giovanni,Fiorentini Chiara,Zanola Alessandra,Lo Harriet P.,Parton Robert G.,Keller Charles,Fanzani Alessandro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference84 articles.

1. Focus on sarcomas;CL Mackall;Cancer Cell,2002

2. Myogenic tumors in children and adolescents;DM Parham;Pediatr Dev Pathol,2012

3. Childhood rhabdomyosarcoma: recent advances and prospective views;C Wang;J Dent Res,2012

4. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis;SJ Tapscott;Science,1993

5. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass;P Dias;Am J Pathol,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer;Frontiers in Oncology;2021-08-26

2. Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin‐4 Deletion Against Ischemia/Reperfusion Injury;Journal of the American Heart Association;2019-08-06